The need for wider utilization of thrombolytic therapy

Clinical Cardiology
C Hennekens

Abstract

Antithrombotic and thrombolytic therapies confer clear net benefits in the treatment of acute myocardial infarction (AMI). Antithrombotic therapy with aspirin yields conclusive reductions in vascular mortality as well as reinfarction and stroke and should be administered to all patients with suspected AMI. There is presently no clear evidence of net benefits from adding either delayed subcutaneous or immediate intravenous heparin to an antithrombotic regimen of aspirin. Direct thrombin inhibitors have theoretical advantages over heparin as antithrombotic agents, but further data are needed from large-scale randomized trials to determine whether these agents confer net benefits when given in conjunction with aspirin. Thrombolytic therapy yields clear reductions in mortality and should be considered for all patients with suspected AMI presenting within 12 h of symptom onset. The differences in the efficacy, safety, or ease of administration of the various thrombolytic agents are small compared with the substantial benefits that would result from the wider use and earlier administration of any of the available agents. More widespread use of antithrombotic and thrombolytic therapies for AMI as well as earlier administration of thro...Continue Reading

References

Jul 24, 1991·JAMA : the Journal of the American Medical Association·M A PfefferB J Gersh
Feb 1, 1990·Archives des maladies du coeur et des vaisseaux
Apr 4, 1985·The New England Journal of Medicine·UNKNOWN TIMI Study Group
Nov 4, 1982·The New England Journal of Medicine·M J StampferC H Hennekens
Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Jan 10, 1994·Archives of Internal Medicine·C H HennekensJ E Buring
Mar 20, 1997·The New England Journal of Medicine·R CollinsP Sleight

❮ Previous
Next ❯

Citations

Oct 16, 2003·International Journal of Cardiology·Ijaz A Khan, Ramesh M Gowda
Nov 20, 2009·The International Journal of Neuroscience·Rivaze KalayciMutlu Küçük
Oct 26, 1999·The American Journal of Emergency Medicine·C W Burt
Feb 2, 2008·Vascular and Endovascular Surgery·Spyros N VasdekisGabriel Karatzas
Mar 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Patricia K AgatisaMargaret K McLaughlin
Oct 27, 2001·Journal of Autonomic Pharmacology·J PenttiläH Scheinin
Apr 17, 2004·Journal of Neurosurgery·Brian A IulianoEdward H Oldfield
Feb 21, 2007·Hypertension·Ana BaracJulio A Panza
Aug 4, 2004·Circulation·Francesco PerticoneCarmine Zoccali
Mar 31, 1999·The Journal of School Health·E J BauerE N Grant
Aug 3, 2005·Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·W Gray JeromeRoy R Hantgan
Jan 1, 1997·Nutrition and Cancer·M D GrossD R Jacobs
Mar 25, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Rheure Alves Moreira LopesRita C Tostes
Aug 19, 2014·Archives of Orthopaedic and Trauma Surgery·Shixiong YiWei Huang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.